Cosmos Pharmaceutical Corp
TSE:3349
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
5 827.5
8 520.0622
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Cosmos Pharmaceutical Corp
Cosmos Pharmaceutical Corp
Cost of Revenue
Cosmos Pharmaceutical Corp
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Cosmos Pharmaceutical Corp
TSE:3349
|
Cost of Revenue
-¥789.3B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-10%
|
|
|
Sundrug Co Ltd
TSE:9989
|
Cost of Revenue
-¥570.9B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-5%
|
|
|
Tsuruha Holdings Inc
TSE:3391
|
Cost of Revenue
-¥724.4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-10%
|
|
|
Welcia Holdings Co Ltd
TSE:3141
|
Cost of Revenue
-¥862.9B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-13%
|
|
|
S
|
Sugi Holdings Co Ltd
TSE:7649
|
Cost of Revenue
-¥547B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-7%
|
|
|
MatsukiyoCocokara & Co
TSE:3088
|
Cost of Revenue
-¥674.9B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-7%
|
|
Cosmos Pharmaceutical Corp
Glance View
COSMOS Pharmaceutical Corp. engages in the operation of drugstores. The company is headquartered in Fukuoka, Fukuoka-Ken and currently employs 4,872 full-time employees. The company went IPO on 2004-11-11. The firm offers medical goods, including general self-medication products, tonic drinks, oral care products, nursing care products, vitamin supplements, health food products, diet food and dispensing. Cosmetic products include cosmetic products for women and men, hair care products and bath agents. Miscellaneous goods include baby goods, detergents, insecticides, deodorizers, bath goods, toiletries, cookware, gardening goods, automobile goods and clothing products. General food products include processed food products, daily food products, seasonings, confectionery, non-alcoholic beverages and alcoholic beverages. The company also provides tobacco and others.
See Also
What is Cosmos Pharmaceutical Corp's Cost of Revenue?
Cost of Revenue
-789.3B
JPY
Based on the financial report for Aug 31, 2024, Cosmos Pharmaceutical Corp's Cost of Revenue amounts to -789.3B JPY.
What is Cosmos Pharmaceutical Corp's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-10%
Over the last year, the Cost of Revenue growth was -14%. The average annual Cost of Revenue growth rates for Cosmos Pharmaceutical Corp have been -11% over the past three years , -10% over the past five years , and -10% over the past ten years .
You don't have any saved screeners yet
